Literature DB >> 12788829

50th anniversary of aldosterone.

Jonathan S Williams1, Gordon H Williams.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12788829     DOI： 10.1210/jc.2003-030490

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  35 in total

1.  Spironolactone and hydrochlorothiazide decrease vascular stiffness and blood pressure in geriatric hypertension.

Authors:  Philip A Kithas; Mark A Supiano
Journal:  J Am Geriatr Soc       Date:  2010-06-01       Impact factor: 5.562

Review 2.  Mechanisms of hypertension: the expanding role of aldosterone.

Authors:  E Marie Freel; John M C Connell
Journal:  J Am Soc Nephrol       Date:  2004-08       Impact factor: 10.121

3.  Does continuous positive airway pressure reduce aldosterone levels in patients with obstructive sleep apnea?

Authors:  Si-Jiu Yang; Xing-Tang Jiang; Xiao-Bin Zhang; Xiao-Wen Yin; Wei-Xian Deng
Journal:  Sleep Breath       Date:  2016-01-15       Impact factor: 2.816

4.  Suspected transient pseudohypoaldosteronism in a 10-day-old quarter horse foal.

Authors:  Luis G Arroyo; Modest Vengust; Howard Dobson; Laurent Viel
Journal:  Can Vet J       Date:  2008-05       Impact factor: 1.008

Review 5.  The Expanding Spectrum of Primary Aldosteronism: Implications for Diagnosis, Pathogenesis, and Treatment.

Authors:  Anand Vaidya; Paolo Mulatero; Rene Baudrand; Gail K Adler
Journal:  Endocr Rev       Date:  2018-12-01       Impact factor: 19.871

Review 6.  The Role of Aldosterone in Obesity-Related Hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Am J Hypertens       Date:  2016-02-28       Impact factor: 2.689

Review 7.  Type 2 diabetes mellitus and hypertension: an update.

Authors:  Guido Lastra; Sofia Syed; L Romayne Kurukulasuriya; Camila Manrique; James R Sowers
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

Review 8.  The role of TGF-β in polycystic ovary syndrome.

Authors:  Nazia Raja-Khan; Margrit Urbanek; Raymond J Rodgers; Richard S Legro
Journal:  Reprod Sci       Date:  2013-04-12       Impact factor: 3.060

Review 9.  Mineralocorticoid receptor antagonists and hypertension: is there a rationale?

Authors:  Olga Gumieniak; Gordon H Williams
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

10.  Aldosterone, through novel signaling proteins, is a fundamental molecular bridge between the genetic defect and the cardiac phenotype of hypertrophic cardiomyopathy.

Authors:  Natalia Tsybouleva; Lianfeng Zhang; Suetnee Chen; Rajnikant Patel; Silvia Lutucuta; Shintaro Nemoto; Gilberto DeFreitas; Mark Entman; Blase A Carabello; Robert Roberts; A J Marian
Journal:  Circulation       Date:  2004-03-01       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.